Auranofin Protects Intestine against Radiation Injury by Modulating p53/p21 Pathway and Radiosensitizes Human Colon Tumor.

Dhrubajyoti NagPayel BhanjaRandal RihaGiselle Sanchez-GuerreroBruce F KimlerTerance T TsueChris LominskaSubhrajit Saha

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)

Our data suggest that auranofin is a potential candidate to be considered as a combination therapy with radiation to improve therapeutic efficacy against abdominal malignancies.

Keyphrases

combination therapy
endothelial cells
electronic health record
signaling pathway
induced pluripotent stem cells
big data
pluripotent stem cells
radiation therapy
climate change
data analysis
artificial intelligence